Cell Therapy News Volume 24.34 | Oct 30 2023

    0
    32








    2023-10-30 | CTN 24.34


    Cell Therapy News by STEMCELL Technologies
    Vol. 24.34 – 30 October, 2023
    TOP STORY

    CLDN6-Specific CAR-T Cells plus Amplifying RNA Vaccine in Relapsed or Refractory Solid Tumors: The Phase I BNT211-01 Trial

    Scientists reported dose escalation results from the ongoing phase I/II BNT211-01 trial evaluating the safety and feasibility of CAR T cells targeting the Claudin 6 (CLDN6) with or without a CAR-T cell-amplifying RNA vaccine at two dose levels in relapsed/refractory CLDN6-positive solid tumors.
    [Nature Medicine]

    Full Article
    PUBLICATIONSRanked by the impact factor of the journal

    CD19 Occupancy with Tafasitamab Increases Therapeutic Index of CART19 Cell Therapy and Diminishes Severity of CRS

    The authors evaluated the potential interference between the CD19-targeting monoclonal antibody tafasitamab and CART19 treatment in preclinical models.
    [Blood]

    Abstract

    Organoids Transplantation Attenuates Intestinal Ischemia/Reperfusion Injury in Mice through L-Malic Acid-Mediated M2 Macrophage Polarization

    Investigators established a method for transplanting intestinal organoids into intestinal ischemia-reperfusion (I/R) mice. They found that transplantation improved mouse survival, promoted self-renewal of intestinal stem cells, and regulated the immune microenvironment after intestinal I/R.
    [Nature Communications]

    Full Article

    Hypoxia-Responsive CAR-T Cells Exhibit Reduced Exhaustion and Enhanced Efficacy in Solid Tumors

    Researchers developed hypoxia-responsive CAR-T cells by engineering the CAR to be under regulation of hypoxia responsive elements and selected the optimal structure, which could be activated in the tumor hypoxic microenvironment to induce CAR-T cells with high polyfunctionality.
    [Cancer Research]

    Abstract

    Magnetic Resonance Imaging of Pancreatic Islets Using Tissue–Adhesive Particles Containing Iron Oxide Nanoparticles

    The authors proposed a novel magnetic resonance imaging contrast agent formulation by encapsulating iron oxide nanoparticles in poly(lactic–co–glycolic acid) particles functionalized with a tissue adhesive polydopamine layer.
    [Journal of Controlled Release]

    AbstractGraphical Abstract

    Alleviation of Ischemia–Reperfusion Induced Renal Injury by Chemically Modified SOD2 mRNA Delivered via Lipid Nanoparticles

    Researchers characterized the protein composition of mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) using a proteomics approach and found that mitochondrial protein superoxide dismutase 2 (SOD2) was enriched in MSC-EVs.
    [Molecular Therapy – Nucleic Acids]

    AbstractFull ArticleGraphical Abstract

    Induced Regeneration of Articular Cartilage: Identification of a Dormant Regeneration Program for a Non-Regenerative Tissue

    An organoid culture model was developed to regenerate articular cartilage by sequential treatment with BMP2 and BMP9 that paralleled induced joint regeneration at digit amputation wounds in vivo.
    [Development]

    Abstract

    Preclinical Long-Term Safety of Intraspinal Transplantation of Human Dorsal Spinal GABA Neural Progenitor Cells

    Investigators characterized the long-term fate and safety of human dorsal spinal γ-aminobutyric acid (GABA) neural progenitor cells (NPCs) in naïve rats over one year. All grafted NPCs had undergone differentiation, yielding mainly neurons and astrocytes.
    [iScience]

    AbstractFull ArticleGraphical Abstract

    The Therapeutic Effects of Gingival Mesenchymal Stem Cells and Their Exosomes in a Chimeric Model of Rheumatoid Arthritis

    A chimeric human/mouse model of synovitis was created by surgically implanting severe combined immunodeficiency disease mice with a piece of human articular cartilage surrounded by synovial fibroblasts.
    [Arthritis Research & Therapy]

    Full Article
    Explore this validated protocol for high-efficiency CRISPR-Cas9 gene editing of Human Primary T Cells.
    REVIEWS

    Expanding Access to CAR T Cell Therapies through Local Manufacturing

    As the numbers of approved products and indications continue to grow, new strategies to increase cell-manufacturing capacity are urgently needed to ensure patient access. Distributed manufacturing at the point of care or at other local manufacturing sites would go a long way toward meeting the rising demand.
    [Nature Biotechnology]

    Abstract

    Engineered Extracellular Vesicles: A Potential Treatment for Regeneration

    The authors comprehensively analyze the engineering methods utilized for modifying donor cells and extracellular vesicles, with a focus on comparing the therapeutic potential between engineered and natural extracellular vesicles.
    [iScience]

    AbstractFull ArticleGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Alberta Cancer Foundation Announces $10 Million in Support of Cellular Therapy Excellence

    At a recent BioAlberta event in Edmonton, the Alberta Cancer Foundation announced a major boost for the province’s cellular therapy program – a revolutionary treatment for cancer that has the potential to dramatically improve survival rates for hard-to-treat cancers.
    [Financial Post]

    Press Release

    Verve’s Base Editing Hold Lifted, Starting a Thaw on a Regulatory Blockade That Sent Peers Ex-US

    A nearly year-long clinical hold on Verve Therapeutics’ base editing therapy meant to treat a genetic form of high cholesterol has been lifted in the US, thanks to data from an ongoing human trial elsewhere in the world and some preclinical work that has allayed the FDA’s concerns.
    [FierceBiotech]

    Press Release
    FEATURED EVENT

    2023 National Pancreas Conference

    November 18 – 19, 2023
    Montréal, Québec, Canada

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Scientist – Cancer Research Cluster

    Cedars-Sinai – Los Angeles, California, United States

    Postdoctoral Researcher – Cancer Immunology and Immunotherapy

    University of Turku – Turku, Finland

    Research Associate – Gene Therapy

    King’s College London – London, England, United Kingdom

    Research Associate – Hematology & Cellular Therapy

    Cedars-Sinai – Los Angeles, California, United States

    Postdoctoral Fellow – Tumor Immunology, Immunotherapy, & Cancer Metastasis

    University of Notre Dame – Notre Dame, Indiana, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Logo for the social media website X